Lifeboat Foundation

Researchers at City of Hope and Translational Genomics Research Institute (TGen) have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws. The study is published in the journal Science Translational Medicine.

“A huge body of evidence shows that cancer caught at later stages kills people. This new technology gets us closer to a world where people will receive a blood test annually to detect cancer earlier when it is more treatable and possibly curable,” said Cristian Tomasetti, Ph.D., corresponding author of the new study and director of City of Hope’s Center for Cancer Prevention and Early Detection.

Tomasetti explained that 99% of people diagnosed with Stage 1 breast cancer will be alive five years later; however, if it is found at Stage 4, when disease has spread to other organs, the five-year survival drops to 31%.

Aging is a common phenomenon among organisms, however, lifespan tends to vary across different species to a significant extent among vertebrates themselves. Aging occurs due to the gradual increase in DNA damage, disruption of cellular organelles, deregulation of protein function, disrupted metabolism and oxidative stress [1].

Longevity. Technology: The differences in lifespan are driven by trade-offs and evolutionary trajectories in the genomes of organisms. Age-specific selection also impacts allele (variations of a gene) frequencies in a population. This in turn impacts environment-specific mortality risk and disease susceptibility. Moreover, mutational processes are influenced by life history and age in both somatic and germline cells.

Now, a new review published in Trends in Genetics discusses recent advances in the evolution of aging at population, organismal and cellular scales.

Biomedical engineers at Duke University have demonstrated that one of the most dangerous mutations found in skin cancers might moonlight as a pathway to mending a broken heart.

The genetic mutation in the protein BRAF, a part of the MAPK signaling pathway that can promote cell division, is one of the most common and most aggressive found in melanoma patients. In a new study, researchers show that introducing this mutation to rat heart tissue grown in a laboratory can induce growth.

Repairing cardiac muscle after a heart attack is the “holy grail” of heart research, complicated by the fact that heart tissue does not regenerate on its own. One potential strategy would be to persuade heart muscle cells to divide by safely delivering a therapeutic gene to patients and fully controlling its activity in the heart.

New vaccine platforms are being developed that could transform access and ease of use for future pandemics, as well as for fighting existing diseases.

“Measles is extremely contagious and there has been an increase in measles cases around the world (with a million more measles cases reported in 2022 than 2021 by the WHO) due to setbacks in measles vaccination rates during the COVID-19 pandemic,” Dr. Monica Gandhi, MPH, a professor of medicine at the University of California San Francisco’s Division of HIV, Infectious Diseases, and Global Medicine, told Healthline. “Members of the public are at risk if they have not been vaccinated (which usually happens in childhood) so the larger population need not be concerned if vaccinations are kept up to date.”

In the last half of 2023, there were more than 20,000 cases of measles in Yemen, the country with the leading outbreak. This is an indicator that without widespread immunity or vaccination, the virus can spread widely, Dr. Tina Tan, an attending physician at Division of Infectious Diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago, told Healthline.

“There are multiple countries around the world where measles is endemic and circulates widely in the community,” Tan said. “With international travel on the increase, unimmunized individuals are getting exposed to measles in the foreign countries that they are visiting, they are getting sick and exposing unimmunized, under immunized and persons that are too young to be immunized or who are unable to be immunized for medical reasons to measles. This has been reported on a number of occasions where exposure is occurring on airplanes, in airports or in the unimmunized person’s community.”

My people.

The Picts, a people who inhabited Scotland during the Middle Ages, have always had a sense of mystery to them. A new study using DNA has revealed new details about their origins.

Continue reading “DNA study reveals the origins of the medieval Picts” »

A 54-atom golden knot is tighter than the knots in DNA and comes close to the theoretical limit of knot size.

Stepping inside Erin Adams’ lab at the University of Chicago is a bit overstimulating.

Adams’ work centers on molecular immunology. As the Joseph Regenstein Professor of Biochemistry and Molecular Biology and vice provost for research, she researches the molecular signals that the immune system uses to distinguish between healthy and unhealthy tissue.

And her lab is expansive. It includes a tissue culture lab space—where she and her team of postdoctoral fellows work with cells to try to recapitulate things. Then there’s the crystal room where one can find hundreds of labeled wells filled with proteins that are being watched to see if three-dimensional crystals materialize.

The humble membranes that enclose our cells have a surprising superpower: They can push away nano-sized molecules that happen to approach them. A team including scientists at the National Institute of Standards and Technology (NIST) has figured out why, by using artificial membranes that mimic the behavior of natural ones. Their discovery could make a difference in how we design the many drug treatments that target our cells.

The team’s findings, which appear in the Journal of the American Chemical Society, confirm that the powerful electrical fields that cell membranes generate are largely responsible for repelling nanoscale particles from the surface of the cell.

This repulsion notably affects neutral, uncharged nanoparticles, in part because the smaller, charged molecules the electric field attracts crowd the membrane and push away the larger particles. Since many drug treatments are built around proteins and other nanoscale particles that target the membrane, the repulsion could play a role in the treatments’ effectiveness.